Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Bakrie Sumatera Plantations Tbk. (UNSP)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Bakrie Sumatera Plantations Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Bakrie Sumatera Plantations Tbk. diperdagangkan di Rp206 (kapitalisasi pasar 495,03 M, volume 24 jam 8,12 jt). Perbedaan utamanya: Bakrie Sumatera Plantations Tbk. jauh lebih besar — sekitar 4,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | UNSP | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 495,03 M |
Volume | — | 8,12 jt |
Lot | — | 81,22 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Bakrie Sumatera Plantations Tbk.
PT Bakrie Sumatra Plantation Tbk (the Company) was established in the Republic of Indonesia in 1911 as a joint venture between the United States and Netherland Companies under the name of NV Hollandsch Amerikaanse Plantage Maatschappij. The Company status is Domestic Investment and has 8822 employees.
Selengkapnya di halaman UNSP →
